Matches in Nanopublications for { ?s ?p "aveed is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone primary hypogonadism congenital or acquired testicular failure due to cryptorchidism bilateral torsion orchitis vanishing testis syndrome orchiectomy klinefelter s syndrome chemotherapy or toxic damage from alcohol or heavy metals these men usually have low serum testosterone concentrations and gonadotropins follicle stimulating hormone fsh luteinizing hormone lh above the normal range hypogonadotropic hypogonadism congenital or acquired gonadotropin or luteinizing hormone releasing hormone lhrh deficiency or pituitary hypothalamic injury from tumors trauma or radiation these men have low testosterone serum concentrations but have gonadotropins in the normal or low range aveed should only be used in patients who require testosterone replacement therapy and in whom the benefits of the product outweigh the serious risks of pulmonary oil microembolism and anaphylaxis limitations of use safety and efficacy of aveed in men with age related hypogonadism also referred to as late onset hypogonadism have not been established safety and efficacy of aveed in males less than 18 years old have not been established see use in specific populations 8 4 aveed testosterone undecanoate injection is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone o primary hypogonadism congenital or acquired 1 o hypogonadotropic hypogonadism congenital or acquired 1 aveed should only be used in patients who require testosterone replacement therapy and in whom the benefits of the product outweigh the serious risks of pulmonary oil microembolism and anaphylaxis 1 limitations of use safety and efficacy of aveed in men with age related hypogonadism have not been established 1 safety and efficacy of aveed in males less than 18 years old have not been established 1 8 4" ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- association label "aveed is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone primary hypogonadism congenital or acquired testicular failure due to cryptorchidism bilateral torsion orchitis vanishing testis syndrome orchiectomy klinefelter s syndrome chemotherapy or toxic damage from alcohol or heavy metals these men usually have low serum testosterone concentrations and gonadotropins follicle stimulating hormone fsh luteinizing hormone lh above the normal range hypogonadotropic hypogonadism congenital or acquired gonadotropin or luteinizing hormone releasing hormone lhrh deficiency or pituitary hypothalamic injury from tumors trauma or radiation these men have low testosterone serum concentrations but have gonadotropins in the normal or low range aveed should only be used in patients who require testosterone replacement therapy and in whom the benefits of the product outweigh the serious risks of pulmonary oil microembolism and anaphylaxis limitations of use safety and efficacy of aveed in men with age related hypogonadism also referred to as late onset hypogonadism have not been established safety and efficacy of aveed in males less than 18 years old have not been established see use in specific populations 8 4 aveed testosterone undecanoate injection is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone o primary hypogonadism congenital or acquired 1 o hypogonadotropic hypogonadism congenital or acquired 1 aveed should only be used in patients who require testosterone replacement therapy and in whom the benefits of the product outweigh the serious risks of pulmonary oil microembolism and anaphylaxis 1 limitations of use safety and efficacy of aveed in men with age related hypogonadism have not been established 1 safety and efficacy of aveed in males less than 18 years old have not been established 1 8 4" assertion.
- association label "aveed is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone primary hypogonadism congenital or acquired testicular failure due to cryptorchidism bilateral torsion orchitis vanishing testis syndrome orchiectomy klinefelter s syndrome chemotherapy or toxic damage from alcohol or heavy metals these men usually have low serum testosterone concentrations and gonadotropins follicle stimulating hormone fsh luteinizing hormone lh above the normal range hypogonadotropic hypogonadism congenital or acquired gonadotropin or luteinizing hormone releasing hormone lhrh deficiency or pituitary hypothalamic injury from tumors trauma or radiation these men have low testosterone serum concentrations but have gonadotropins in the normal or low range aveed should only be used in patients who require testosterone replacement therapy and in whom the benefits of the product outweigh the serious risks of pulmonary oil microembolism and anaphylaxis limitations of use safety and efficacy of aveed in men with age related hypogonadism also referred to as late onset hypogonadism have not been established safety and efficacy of aveed in males less than 18 years old have not been established see use in specific populations 8 4 aveed testosterone undecanoate injection is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone o primary hypogonadism congenital or acquired 1 o hypogonadotropic hypogonadism congenital or acquired 1 aveed should only be used in patients who require testosterone replacement therapy and in whom the benefits of the product outweigh the serious risks of pulmonary oil microembolism and anaphylaxis 1 limitations of use safety and efficacy of aveed in men with age related hypogonadism have not been established 1 safety and efficacy of aveed in males less than 18 years old have not been established 1 8 4" assertion.